Category:
What’s the “value” of exome sequencing in children with neurodevelopmental disorders?
This is a summary of a recent commentary in Genetics in Medicine by Grosse and Rasmussen. Exome sequencing (ES) is increasingly used as part of the genetics evaluation of neurodevelopmental disorders, and acute illness in newborns of suspected genetic origin, among others. However, barriers to the clinical use of ES include a widespread reluctance of insurers Read More >
Posted on byCan a Healthy Lifestyle Reduce Your Risk of Dementia Regardless of Your Genes? – Part II
A new, long term cohort study suggests that healthy lifestyle is associated with a lower risk for dementia among people considered at lower and intermediate genetic risk but not for those considered at high genetic risk. “Globally, about 47 million people were living with dementia in 2015, and this number is projected to triple by Read More >
Posted on byCan an Aspirin a Day Prevent Colorectal Cancer in People with Lynch Syndrome?
Encouraging news for group at much greater risk of CRC Lynch syndrome (LS) is the most common cause of hereditary colorectal (colon) cancer (CRC). People with LS have a 50-70% risk of developing CRC in their lifetimes – far higher than the 4% risk within the general population where CRC is a leading cause of Read More >
Posted on by